Stereotaxis Announces

Related by string. * : Stereotaxis NASDAQ STXS . Stereotaxis Niobe . PRNewswire FirstCall Stereotaxis . Stereotaxis designs manufactures . Stereotaxis Odyssey ™ . Stereotaxis System / announc ed . ANNOUNCES . ANNOUNCE . announce . announces : Announces Second Quarter . Announces Third Quarter . Announces Fourth Quarter . Announce Partnership . Announces Launch . Announce Fourth Quarter * *

Related by context. Frequent words. (Click for all words.) 71 Stronger Than Expected 71 Mechel Announces 70 Annual Meeting Date 70 Updates Guidance 69 Provides Shareholder 68 Record Second Quarter 68 Reports Profitable 68 Improves Survival 68 Explore Strategic Alternatives 68 Dividend Declared 68 Clinical Trial Results 68 Secures Financing 68 Internationally Recognized 68 Upcoming Conferences 68 Review Initiated 68 Record Third Quarter 67 Previously Announced 67 Second Quarter Dividend 67 Patient Enrollment 67 Vertex Pharmaceuticals Announces 67 FY# Guidance 67 Milestone Payment 67 Profitable Quarter 67 MITTEILUNG UEBERMITTELT VON BUSINESS 67 Reaffirms Guidance 67 1st Quarter Results 67 Guidance Quick Facts 66 Guides FY# 66 Japanese Stocks Climb 66 Hold Fourth Quarter 66 Jumps Higher 66 Dividend Announcement 66 Key Milestones 66 Growth Accelerates 66 Q1 Loss Narrows 66 Hold Third Quarter 66 StockSource.us Reports 66 Opns 66 FDA Clears 66 Drop Sharply 66 Successful Completion 66 Record Fourth Quarter 66 Weaker Than Expected 66 Provides Guidance 66 Sees Positive 66 Positive Cash Flow 66 Updates Shareholders 65 Q3 Loss Narrows 65 Meets Primary Endpoint 65 Announces FDA Clearance 65 Mixed Ahead 65 3rd Quarter Results 65 Preliminary Third Quarter 65 Revenues Decline 65 Significant Increase 65 Preliminary Second Quarter 65 Nine Month 65 Less Than Forecast 65 Completes Enrollment 65 Rise Slightly 65 2nd Quarter Results 65 Arthritis Drug 65 More Than Doubled 65 Receives Notification 65 Net Loss Narrows 65 Higher Than Expected 65 Approve Merger 65 Phase III Trial 65 美 通 社 65 Cautious Optimism 65 Investors Await 65 Osteoporosis Drug 65 Two Investor Conferences 65 Increases Productivity 65 Prostate Cancer Patients 65 Inch Higher 65 Stock Buyback Program 64 Receives Orphan Drug Designation 64 Reconfirms 64 Preclinical Data 64 Releases Second Quarter 64 Momentum Continues 64 Blood Thinner 64 M d yyyy 64 Consumer Confidence Drops 64 Complete Merger 64 Sets Annual Meeting 64 Cervical Cancer Vaccine 64 Gap Narrows 64 Achieves Milestone 64 Flu Vaccines 64 Inhaled Insulin 64 Study Evaluating 64 Fall Sharply 64 Jobless Claims Drop 64 Q4 Loss Narrows 64 FDA Accepts 64 Forges Ahead 64 Announces Cash Dividend 64 Drug Shows Promise 64 Provides Updates

Back to home page